LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway

Liver cancer remains one of the leading causes of cancer deaths worldwide. The therapeutic effect of oxaliplatin on liver cancer is often limited by acquired resistance of the cancer cells. Abnormal activation of the PI3K/AKT pathway plays an important role in the acquired resistance of oxaliplatin....

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Med Rep
Main Authors: Xu, Ruyue, Zhang, Yinci, Li, Amin, Ma, Yongfang, Cai, Wenpeng, Song, Li, Xie, Yinghai, Zhou, Shuping, Cao, Weiya, Tang, Xiaolong
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2021
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8134878/
https://ncbi.nlm.nih.gov/pubmed/33982772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2021.12147
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍